OBIO
Orchestra BioMed Holdings Inc

531
Mkt Cap
$263.69M
Volume
144,471.00
52W High
$6.30
52W Low
$2.20
PE Ratio
-2.51
OBIO Fundamentals
Price
$4.57
Prev Close
$4.67
Open
$4.66
50D MA
$3.99
Beta
1.69
Avg. Volume
360,923.11
EPS (Annual)
-$1.66
P/B
5.90
Rev/Employee
$37,685.71
Loading...
Loading...
News
all
press releases
Orchestra BioMed (NASDAQ:OBIO) Earns Buy Rating from Analysts at TD Cowen
TD Cowen began coverage on Orchestra BioMed in a report on Wednesday. They set a "buy" rating and a $15.00 price target for the company...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Average Rating of "Moderate Buy" by Analysts
Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) have been given an average recommendation of "Moderate Buy" by the six ratings firms that are currently covering the company...
MarketBeat·3d ago
News Placeholder
David Hochman Acquires 5,000 Shares of Orchestra BioMed (NASDAQ:OBIO) Stock
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) insider David Hochman purchased 5,000 shares of the firm's stock in a transaction that occurred on Friday, November 14th. The shares...
MarketBeat·23d ago
News Placeholder
Orchestra BioMed (NASDAQ:OBIO) Insider Buys $20,350.00 in Stock
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) insider David Hochman acquired 5,000 shares of Orchestra BioMed stock in a transaction that occurred on Friday, November 14th. The...
MarketBeat·24d ago
News Placeholder
Research Analysts Offer Predictions for OBIO FY2025 Earnings
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Free Report) - Research analysts at HC Wainwright cut their FY2025 EPS estimates for Orchestra BioMed in a research note issued on Thursday, November...
MarketBeat·25d ago
News Placeholder
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six brokerages that are currently covering the firm, Marketbeat reports. One...
MarketBeat·27d ago
News Placeholder
Barclays Has Lowered Expectations for Orchestra BioMed (NASDAQ:OBIO) Stock Price
Barclays dropped their target price on shares of Orchestra BioMed from $12.00 to $11.00 and set an "overweight" rating on the stock in a report on Wednesday...
MarketBeat·29d ago
News Placeholder
Orchestra BioMed (NASDAQ:OBIO) Releases Earnings Results, Misses Expectations By $0.02 EPS
Orchestra BioMed (NASDAQ:OBIO - Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.40) EPS for the quarter, topping analysts' consensus estimates of ($0.44) by...
MarketBeat·1mo ago
News Placeholder
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Beats Revenue Estimates
Orchestra BioMed Holdings, Inc. (OBIO) delivered earnings and revenue surprises of -5.26% and +15.42%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Orchestra BioMed Holdings Q3 Loss Widens
(RTTNews) - Orchestra BioMed Holdings, Inc. (OBIO) Monday reported a third-quarter net loss of $20.8 million or $0.40 per share, compared with a net loss of $15.4 million or $0.41 per share for the...
Nasdaq News: Markets·1mo ago

Latest OBIO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.